149 related articles for article (PubMed ID: 11313693)
61. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
[TBL] [Abstract][Full Text] [Related]
62. Dermatomyositis and sarcoid-like reaction associated with multiple myeloma treated effectively by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Chakraverty R; Rabin N; Peggs K; Robinson S; Duncan JR; Yong K
Bone Marrow Transplant; 2001 Jun; 27(11):1215-7. PubMed ID: 11551034
[TBL] [Abstract][Full Text] [Related]
63. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
[TBL] [Abstract][Full Text] [Related]
64. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
65. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
[TBL] [Abstract][Full Text] [Related]
66. Coexistence of aneuploid subclones within a myeloma cell line that exhibits clonal immunoglobulin gene rearrangement: clinical implications.
Jelinek DF; Ahmann GJ; Greipp PR; Jalal SM; Westendorf JJ; Katzmann JA; Kyle RA; Lust JA
Cancer Res; 1993 Nov; 53(21):5320-7. PubMed ID: 8221668
[TBL] [Abstract][Full Text] [Related]
67. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
68. [B-cell acute lymphoblastic leukemia developed 5 years after autologous stem cell transplantation for multiple myeloma].
Tsukada Y; Hattori Y; Nakajima H; Yokoyama K; Murata M; Shimizu N; Kondo N; Okamoto S
Rinsho Ketsueki; 2012 Feb; 53(2):219-23. PubMed ID: 22450582
[TBL] [Abstract][Full Text] [Related]
69. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
70. [A high serum level of interleukin-6 in a patient with aggressive multiple myeloma].
Abe Y; Muta K; Kato S; Sadamura S; Nishimura J; Nawata H; Takeichi N; Sakai K
Rinsho Ketsueki; 1991 Nov; 32(11):1458-62. PubMed ID: 1758053
[TBL] [Abstract][Full Text] [Related]
71. Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: clinical response after plasma exchange.
Focosi D; Pelosini M; Palla P; Galimberti S; Caracciolo F; Benedetti E; Papineschi F; Petrini M
Transpl Immunol; 2009 Sep; 21(4):240-3. PubMed ID: 19539028
[TBL] [Abstract][Full Text] [Related]
72. Plasma cell leukemia: from biology to treatment.
Jelinek T; Kryukov F; Rihova L; Hajek R
Eur J Haematol; 2015 Jul; 95(1):16-26. PubMed ID: 25778450
[TBL] [Abstract][Full Text] [Related]
73. Acute lymphoblastic leukemia after tandem autologous stem cell transplantations for multiple myeloma.
Lau LG; Tan LK; Koay ES; Liu TC
Leukemia; 2005 Feb; 19(2):299-301. PubMed ID: 15526017
[No Abstract] [Full Text] [Related]
74. [A case of central nervous system myelomatosis with complex chromosome aberrations].
Bang HI; Yoo JY; Kim KH; Park R; Shin JW; Choi TY; Lee SC; Park HS; Won JH
Korean J Lab Med; 2010 Aug; 30(4):334-8. PubMed ID: 20805703
[TBL] [Abstract][Full Text] [Related]
75. Patterns of central nervous system involvement in relapsed and refractory multiple myeloma.
Abdallah AO; Atrash S; Shahid Z; Jameel M; Grazziutti M; Apewokin S; Kumar NS; Restrepo A; Waheed S; Van Rhee F; Heuck CJ; Johann D; Barlogie B; Usmani SZ
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):211-4. PubMed ID: 24373936
[TBL] [Abstract][Full Text] [Related]
76. Unequal results of collection of peripheral blood stem cells in view of autografting in high risk multiple myeloma.
Eisenmann JC; Hénon P; Wunder E; Lepers M; Beck-Wirth G; Debecker A; Prévot G
Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():56-7. PubMed ID: 1969316
[No Abstract] [Full Text] [Related]
77. Parkinsonian syndrome in a dialysis-supported patient receiving high-dose chemotherapy for multiple myeloma.
Fleming DR; Mangino PB
South Med J; 1997 Mar; 90(3):364-5. PubMed ID: 9076316
[No Abstract] [Full Text] [Related]
78. Myeloma stem cells in autografting in multiple myeloma.
To LB; Horvath N; Dyson P; Henry J; Sykes P; Brisco M; Morley A; Bennetts B
J Hematother; 1996 Oct; 5(5):557-9. PubMed ID: 8938529
[TBL] [Abstract][Full Text] [Related]
79. Multiple myeloma.
Smith D; Yong K
BMJ; 2013 Jun; 346():f3863. PubMed ID: 23803862
[No Abstract] [Full Text] [Related]
80. An update of the management of multiple myeloma: the changing landscape.
Reece DE
Hematology Am Soc Hematol Educ Program; 2005; ():353-9. PubMed ID: 16304403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
